Zambon unit and Yissum cooperate on nano drug delivery

Z-Cube Srl, the corporate venture arm of Italy's Zambon Co, and Yissum Research Development Co, the technology transfer company of the Hebrew  University of Jerusalem, have entered into a license agreement for the  former to develop and commercialize an innovative nanotechnology drug  delivery system for the treatment of pain. The technology was invented  by Elka Touitou, a professor at the Department of Pharmaceutics, Faculty  of Medicine, at the Hebrew University of Jerusalem.

Under the terms of the agreement, Z-Cube has received the worldwide  exclusive right to develop and commercialize the technology for pain  applications and will sponsor a research program to be conducted by Prof  Touitou and her group. Z-Cube has also received the right to grant  sub-licenses. Yissum will receive license fees, milestones and royalty  payments.